Abstract

BackgroundAllostery is one of the most powerful and common ways of regulation of protein activity. However, for most allosteric proteins identified to date the mechanistic details of allosteric modulation are not yet well understood. Uncovering common mechanistic patterns underlying allostery would allow not only a better academic understanding of the phenomena, but it would also streamline the design of novel therapeutic solutions. This relatively unexplored therapeutic potential and the putative advantages of allosteric drugs over classical active-site inhibitors fuel the attention allosteric-drug research is receiving at present. A first step to harness the regulatory potential and versatility of allosteric sites, in the context of drug-discovery and design, would be to detect or predict their presence and location. In this article, we describe a simple computational approach, based on the effect allosteric ligands exert on protein flexibility upon binding, to predict the existence and position of allosteric sites on a given protein structure.ResultsBy querying the literature and a recently available database of allosteric sites, we gathered 213 allosteric proteins with structural information that we further filtered into a non-redundant set of 91 proteins. We performed normal-mode analysis and observed significant changes in protein flexibility upon allosteric-ligand binding in 70% of the cases. These results agree with the current view that allosteric mechanisms are in many cases governed by changes in protein dynamics caused by ligand binding. Furthermore, we implemented an approach that achieves 65% positive predictive value in identifying allosteric sites within the set of predicted cavities of a protein (stricter parameters set, 0.22 sensitivity), by combining the current analysis on dynamics with previous results on structural conservation of allosteric sites. We also analyzed four biological examples in detail, revealing that this simple coarse-grained methodology is able to capture the effects triggered by allosteric ligands already described in the literature.ConclusionsWe introduce a simple computational approach to predict the presence and position of allosteric sites in a protein based on the analysis of changes in protein normal modes upon the binding of a coarse-grained ligand at predicted cavities. Its performance has been demonstrated using a newly curated non-redundant set of 91 proteins with reported allosteric properties. The software developed in this work is available upon request from the authors.

Highlights

  • Allostery is one of the most powerful and common ways of regulation of protein activity

  • We started by integrating the 146 allosteric site entries that were, at the time of this writing, annotated in the AlloSteric Database (ASD) [13] with another 72 allostery examples we had previously found in the literature

  • Allosteric-ligand presence affects protein flexibility Our first experiment aimed at quantifying the number of proteins in our data set that undergo a significant change in flexibility when the allosteric ligand is bound

Read more

Summary

Introduction

Allostery is one of the most powerful and common ways of regulation of protein activity. Uncovering common mechanistic patterns underlying allostery would allow a better academic understanding of the phenomena, but it would streamline the design of novel therapeutic solutions. This relatively unexplored therapeutic potential and the putative advantages of allosteric drugs over classical active-site inhibitors fuel the attention allosteric-drug research is receiving at present. Allosteric sites tend to be under lower sequence-conservation pressure than active sites, facilitating the design of highly specific drugs and reducing the risks of toxicity or sideeffects [5,6,7] To explain this briefly, if the pathogen’s active site is very well conserved in nature it may share important structural features with the human homologue, which could be bound and inhibited as well by the antimicrobial drug causing toxic side-effects on the patient. Traditional drugs may be complemented by allosteric effectors, as observed in the case of aminoglycoside phosphotransferase where a previously unknown binding site could be exploited to allosterically counteract antibiotic resistance [10]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.